ARTICLES BY THIS AUTHOR
- 7/10/2022
Amring joins The End Drug Shortages Alliance
Amring said that it will work with the alliance to develop collaborative mitigation strategies to address issues contributing to drug shortages. - 7/10/2022
CVS Health study finds people embracing holistic outlook on health
CVS Health’s 2022 Health Care Insights study highlights consumers’ preferences for a new kind of healthcare experience and their openness to nontraditional options, as well as holistic care choices involving diet, exercise and counseling. - 7/7/2022
Canviiy standouts in organic scalp care
Canviiy's founder, Sherrel Sampson, shares her mission in providing long-lasting, concentrated scalp care formulas based in plant science and infused with powerful, natural botanicals. - 7/7/2022
CVS Health appoints new executive
Tilak Mandadi will be responsible for the company’s data, digital and technology strategy while overseeing growth and innovation through digital-led, consumer-focused experiences and services. - 7/7/2022
Pharmacy groups praise FDA for authorizing pharmacists to prescribe Paxlovid
NACDS and NCPA commended the FDA for authorizing pharmacists to prescribe Paxlovid, but continue to urge the government to take action to ensure pharmacists are reimbursed for their services. - 7/7/2022
LeBron James’, Arnold Schwarzenegger’s Ladder debuts at The Vitamin Shoppe
Ladder's products are now exclusively available at 690 The Vitamin Shoppe locations. - 7/7/2022
Teva taps Eric Hughes as chief medical officer
Hughes brings nearly 20 years of leadership roles, with a proven track record in a variety of R&D functions, to global pharmaceutical companies, Teva said. - 7/7/2022
Southeastern Grocers donates $1.2M to Folds of Honor
The community donation program will provide more than 250 educational scholarships to the children and spouses of America’s fallen and disabled service members. - 7/6/2022
Cardinal Health’s Outcomes acquires smart prescription platform ScalaMed
ScalaMed pivots prescription management from provider to patient, allowing patients to send prescriptions written by their provider directly to any pharmacy for the first fill. - 7/6/2022
Elite Pharmaceuticals secures FDA approval for generic Sabril
Vigabatrin is an antiepileptic drug indicated for refractory complex partial seizures and used as an adjunctive therapy in patients who have inadequately responded to several alternative treatments.